Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Abstract | Full HTML Article | PDF ecancer 9 549 / https://doi.org/10.3332/ecancer.2015.549

Case Report

Sentinel node detection in endometrial cancer using indocyanine green and fluorescence imaging—a case report

Anupama Rajanbabu, R Venkatesan, Satish Chandramouli and P V Nitu

Amrita institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala 682041, India

Correspondence to: Anupama Rajanbabu. Email: anupamashyam@gmail.com


Sentinel lymph node mapping in endometrial cancer can help to provide the prognostic information needed while avoiding the morbidity associated with a complete lymphadenectomy. Studies with blue dye and technetium colloid have only given about 80% detection rates whereas with indocyanine green injection and fluorescence imaging, it gives about 88–100% detection rates. Herein, we report a case where indocyanine green was injected intracervically and sentinel nodes were detected at the paraaortic nodal area.

Keywords: endometrial cancer, sentinel node, fluorescent lymphoscintigraphy

Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published: 29/06/2015; Received: 27/04/2015


Lymphadenectomy in endometrial cancer is a topic of ongoing debate. The presence of lymph node involvement is one of the most important prognostic factors in endometrial cancer, but the therapeutic benefit of lymphadenectomy is doubtful. The technique of sentinel lymph node (SLN) mapping has relevance in this scenario as it can provide the prognostic information needed while avoiding the morbidity associated with a complete lymphadenectomy [1]. Many studies have come up with cervical, subserosal, and hysteroscopic injections using blue dye and technetium-99 colloid, but this has detection rates of less than 80% [1, 2]. The use of near infrared fluorescence imaging after intracervical injection with indocyanine green (ICG) dye has given 87–100% detection rates and hence appears superior to the use of blue dye or radioactive colloid [37]. We report a case of SLN mapping using ICG and fluorescence imaging in endometrial cancer which is the first case carried out in India.

Case report

A 57-year-old lady reported to our institution with an endometrial biopsy showing well-differentiated adenocarcinoma. Slide review confirmed the diagnosis. Magnetic resonance imaging (MRI) of the pelvis showed a 3 × 2 cm lesion in the endometrial cavity with superficial myometrial invasion without any enlarged pelvic or paraaortic nodes. She underwent robotic staging surgery for carcinoma endometrium in February 2015 using the da Vinci Xi robotic platform. As there is facility for fluorescence imaging in the robotic platform, it was decided to use ICG for sentinel mapping in her. Consent for the procedure was obtained from the patient and also from the hospital’s ethical committee.

Concentration of ICG used was 0.5 mg/mL, a 4 mL of this solution was injected intracervically at 3 and 9 o’clock positions, both submucosally and deep into the cervical stroma. The injection was done after port placement but before the docking of the robotic platform. After complete inspection of peritoneal cavity and collecting pelvic washings, the fluorescent imaging was switched on. The time taken from the cervical injection till this point was 20 minutes. Under fluorescence imaging, the site of intracervical injection was well lit up but no lymphatics or lymph nodes were identified in the pelvic nodal areas. We then looked into the paraaortic area with fluorescence imaging and saw a lit up lymphatic channel crossing the right common iliac and lighting up of a right periaortic node (Figure 1). Bilateral pelvic lymphadenectomy and removal of the lighted up paraaortic nodes were done. Complete paraaortic nodal dissection was not done as it is our practice to do paraaortic lymphadenectomy for high-risk histologies.

Figure 1. A) Appearance of pelvic area under normal light. B) Pelvic area with fluorescent imaging showing lighting up of the injection site. No lymphatics are seen going to the pelvic nodes. C) Paraaortic area seen under normal light. D) Paraaortic area with fluorescent imaging showing the lymphatic crossing right common iliac artery near the bifurcation and going to the right periaortic node just below the duodenum.

Histopathology report showed 4.5 × 4 × 2.5 cm grade 2 endometrioid carcinoma infiltrating to outer one-half of the myometrium with lymphovascular emboli. Two out of three paraaortic nodes removed were positive for tumour metastasis. Three out of 11 left iliac nodes were also found to be positive, and the ten right iliac nodes removed were found to be negative. The case was discussed by the multidisciplinary tumour board, and it was decided to give her adjuvant radiotherapy with chemotherapy in view of node positivity.


The use of SLN mapping in endometrial cancer is gaining in acceptance [47]. A metaanalysis involving 26 studies using blue dye of radioactive colloid have shown a 78% detection rate for SLN mapping in endometrial cancer which is lower than that for melanoma, breast cancer, or colorectal cancer [2]. Intracervical injection of ICG followed by fluorescent imaging appears to be a simpler technique with improved detection rates [4]. We had tried sentinel node detection for endometrial cancer using blue dye and technetium previously, but the detection of the nodes was very difficult. This was our first experience with ICG injection followed by fluorescent imaging and the technique appeared simple providing clear view of the sentinel node. More prospective studies are needed to validate the accuracy of this method.


1. Burke TW et al (1996) Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study Gynecol Oncol 62(2) 169–73 DOI: 10.1006/gyno.1996.0211 PMID: 8751545

2. Kang S et al (2011) Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies Gynecol Oncol 123(3) 522–7 DOI: 10.1016/j.ygyno.2011.08.034 PMID: 21945553

3. Rossi EC, Ivanova A and Boggess JF (2012) Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study Gynecol Oncol 124(1) 78–82 DOI: 10.1016/j.ygyno.2011.09.025

4. Jewell EL et al (2014) Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies Gynecol Oncol 133(2) 274–7 DOI: 10.1016/j.ygyno.2014.02.028 PMID: 24582865

5. Holloway RW et al (2012) Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging Gynecol Oncol 126(1) 25–9 DOI: 10.1016/j.ygyno.2012.04.009 PMID: 22507531

6. Plante M et al (2015) Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature Gynecol Oncol 137(3) 443–7 DOI: 10.1016/j.ygyno.2015.03.004 PMID: 25771495

7. How J et al (2015) Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer Gynecol Oncol 137(3) 436–42 DOI: 10.1016/j.ygyno.2015.04.004 PMID: 25870917

Keywords: endometrial cancer, Sentinel node, fluorescent lymphoscintigraphy

Loading Article Metrics ... Please wait

Related articles

Research: Depression and quality of life in patients with breast cancer undergoing chemotherapy and monoclonal antibodies

Abstract | Full Article | PDF Published: 10 Jul 2019 / https://doi.org/10.3332/ecancer.2019.937

Review: Challenges and shifting paradigms in clinical trials in oncology, the case for immunological and targeted therapies

Abstract | Full Article | PDF Published: 05 Jul 2019 / https://doi.org/10.3332/ecancer.2019.936

Research: Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse

Abstract | Full Article | PDF Published: 27 Jun 2019 / https://doi.org/10.3332/ecancer.2019.935

Research: Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy

Abstract | Full Article | PDF Published: 06 Jun 2019 / https://doi.org/10.3332/ecancer.2019.934

Case Report: Two cases of gastric mucosa-associated lymphoid tissue (MALT) lymphoma masquerading as follicular gastritis

Abstract | Full Article | PDF Published: 03 Jun 2019 / https://doi.org/10.3332/ecancer.2019.933

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation